Retrophin

FDA Action Alert: Regeneron, Sanofi, Celgene
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
FDA
drug approvals
Acer Therapeutics
Edsivo
Regeneron
Sanofi
Dupixent
Celgene
Revlimid
Alexion
Soliris
Dova Pharmaceuticals
Doptelet
Nabriva Therapeutics
Contepo
Retrophin
Thiola
Flag link:
After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin
After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin
Endpoints
Martin Shkreli
Retrophin
Flag link:
Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues
Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues
Endpoints
Martin Shkreli
Retrophin
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Go or no go? Merck, Regeneron and Alexion await US expansion
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
Flag link:
Made for TV: Shkreli running his drug company from prison cell, WSJ says
Made for TV: Shkreli running his drug company from prison cell, WSJ says
Fierce Pharma
Martin Shkreli
Phoenixus
Retrophin
Flag link:
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Endpoints
R&D
Martin Shkreli
RE-0024
Retrophin
Cyprus
clinical trials
Flag link:
From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
Fierce Pharma
Martin Shkreli
fraud
Retrophin
Flag link:
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Endpoints
Martin Shkreli
biotech
Retrophin
fraud
Flag link:
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Bizjournals.com
Retrophin
Cambridge
Martin Shkreli
Flag link:
Martin Shkreli in court as securities fraud case moves closer to trial
Martin Shkreli in court as securities fraud case moves closer to trial
CNBC
Martin Shkreli
securities fraud
Retrophin
Flag link:
4 Key BioPharma Movers in the Past Week
4 Key BioPharma Movers in the Past Week
24/7 Wall St
Retrophin
Evoke Pharma
Celgene
Lexicon Pharmaceuticals
Flag link:
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
TheStreet.com
Retrophin
Martin Shkreli
sparsentan
kidney disease
focal segmental glomerulosclerosis
Flag link:
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Shire
Raptor Pharmaceuticals
M&A
Retrophin
Rare Diseases
Flag link:
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Bloomberg
Raptor Pharmaceuticals
Retrophin
Martin Shkreli
Flag link:
Facing new conspiracy charge, Martin Shkreli pleads not guilty
Facing new conspiracy charge, Martin Shkreli pleads not guilty
Marketwatch
Martin Shkreli
Retrophin
Flag link:
More charges against ex-pharmaceutical executive Shkreli
More charges against ex-pharmaceutical executive Shkreli
Yahoo/AP
Martin Shkreli
Retrophin
Flag link:
Even more charges are probably coming Martin Shkreli’s way
Even more charges are probably coming Martin Shkreli’s way
Marketwatch
Martin Shkreli
Retrophin
Flag link:
How Did Martin Shkreli Ever Become A Pharmaceutical CEO?
How Did Martin Shkreli Ever Become A Pharmaceutical CEO?
Forbes
Martin Shkreli
Pharma CEOs
Turing Pharmaceuticals
Retrophin
Flag link:
The company that took on Martin Shkreli's drug-price hikes has a new target
The company that took on Martin Shkreli's drug-price hikes has a new target
Yahoo/Business Insider
Martin Shkreli
Thiola
Retrophin
drug pricing
cystinuria
Imprimis Pharmaceuticals
Flag link:

Pages